secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001628280-24-007807
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel reports FY2023 revenue $197.5M (+20% YoY); Q4 revenue $65.0M; FY2024 guidance $237-241M
--------------------------------------------------------------------------------

- Q4 net income $13.0M ($0.26 diluted EPS) vs $5.9M in Q4 2022, up 119%.
- FY2023 net loss narrowed to $3.2M from $16.7M; adjusted EBITDA $33.9M (+40%).
- MACI net revenue grew 22% to $56.7M in Q4; Burn Care revenue up 31% to $8.3M.
- FY2024 total revenue guidance $237-241M; gross margin ~70%; adj. EBITDA margin ~20%.
- Cash and investments $152.6M, zero debt; MACI arthroscopic delivery submission accepted by FDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828024007807/0001628280-24-007807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828024007807/vcel-20240229.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-007807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer